Evidence map›Paper›PMID 40726240›Full record

ArticleJournal of Korean medical science2025

Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.

Heayeon Lee, Bora Lee, Sei Won Kim, Chang Dong Yeo, Sang Haak Lee, Jihyang Lim

Abstract read
In one paragraph

Article in Journal of Korean medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heayeon LeeDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0001-7389-2343
Bora LeeDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0003-1381-7506
Sei Won KimDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-2798-421X
Chang Dong YeoDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-4103-7921
Sang Haak LeeDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0001-6259-7656
Jihyang LimDepartment of Laboratory Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ljh117@catholic.ac.kr.ORCID https://orcid.org/0000-0003-1459-8843

Funding

Catholic Medical CenterNational Research Foundation of Korea NRF-2022R1C1C1009134
6 · The paper itself

Abstract

backgroundThe studies about the characteristics of immune systems and lymphocyte subset counts regarding coronavirus disease 2019 (COVID-19) have been conducted in a number of ways, however studies on the difference of lymphocyte subset counts according to each severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant are rare. As each country has a different quarantine system, it is necessary to investigate the characteristics in places such as South Korea where the vaccination rate is high and a thorough national quarantine system is being operated. The aim of this study was to investigate the difference in peripheral blood lymphocyte subset counts in COVID-19 patients in South Korea according to their disease severity and SARS-CoV-2 variants.

methodsA total of 148 hospitalized COVID-19 patients enrolled in this study at Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea. SARS-CoV-2 infection was confirmed using real-time quantitative polymerase chain reaction and COVID-19 severity was divided into three groups (mild, moderate, and severe) at the time of admission, according to the treatment types of oxygen support. Laboratory tests were performed for evaluation of inflammatory status. The peripheral lymphocyte subset counts were analyzed using flow cytometry at the time of admission in all 148 patients and after treatment in 65 patients with moderate or severe severity. We analyzed the changes of peripheral lymphocyte subset counts according to three COVID-19 severity groups and three SARS-CoV-2 variants (wild and alpha, delta and omicron variants).

resultsAt admission, total T, CD4+ T, CD8+ T, natural killer (NK), and NKT cell counts decreased, but B cells did not change significantly depending on severity. There were markedly decreased in total T, CD4+ T, CD8+ T, and NK cells in the delta and omicron variants and not in the wild and alpha variant. After treatment in patients with moderate or severe severity, most lymphocyte subset counts were increased except the NK cells. Lower total lymphocyte counts, especially total T lymphocyte counts were associated with a higher occurrence of severe COVID-19.

conclusionThe peripheral lymphocyte subset counts decreased according to disease severity and the types of SARS-CoV-2 variants in hospitalized COVID-19 patients. Despite the efficient operation of the national quarantine system and high vaccination rates in South Korea, it suggests that viral mutations evolve in a direction that further weakens the immune system. This is the only study on the difference in peripheral lymphocyte subset counts according to COVID-19 severity and SARS-CoV-2 variants conducted in South Korea, and therefore our data could be used as an important reference for another pandemic situation in the future.

Indexed as

COVID-19Lymphocyte SubsetsSARS-CoV-2AdultAgedAged, 80 and overCD8-Positive T-LymphocytesFemaleHospitalizationHumansLymphocyte CountMaleMiddle AgedRepublic of KoreaSeverity of Illness IndexCOVID-19Lymphocyte Subset CountSARS-CoV-2SeverityVariant

Identifiers

PMID40726240
PMCPMC12303659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.